Sally Morrison-Griffiths
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Sally Morrison-Griffiths has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Munir Pirmohamed
University of Liverpool Department of Pharmacology and Therapeutics
5 shared publications Alasdair M Breckenridge
Department of Pharmacology and Therapeutics, University of Liverpool, Ashton Street, Liverpool L69 3GE, UK
1 shared publicationB Kevin Park
Department of Pharmacology and Therapeutics, University of Liverpool, Ashton Street, Liverpool L69 3GE, UK
1 shared publicationColm O'Mahony
Department of Genitourinary Medicine, Countess of Chester Hospital , Chester CH2 1UL, UK
1 shared publicationMark Newman
Department of Genitourinary Medicine, Countess of Chester Hospital , Chester CH2 1UL, UK
1 shared publicationT Walley
1 shared publication
Latest Publications
- 1 April 2003
- Published by Elsevier in The Lancet
- Vol. 361 (9366) , 1347-1348
Reporting of adverse drug reactions by nurses
- 1 April 2003
- Published by Elsevier in The Lancet
- Vol. 361 (9366) , 1347-1348
Reporting of adverse drug reactions by nurses
- 1 August 2002
- Published by Elsevier in Nurse Education Today
- Vol. 22 (6) , 447-456
Pre-registration nurse education in pharmacology: is it adequate for the roles that nurses are expected to fulfil?
- 1 August 2002
- Published by Elsevier in Nurse Education Today
- Vol. 22 (6) , 447-456
Pre-registration nurse education in pharmacology: is it adequate for the roles that nurses are expected to fulfil?
- 1 February 2000
- Vol. 15 (5) , 300-4
Specialist nurse reporting of adverse drug reactions.
Up to 36% of inpatients experience an adverse drug reaction (ADR) while in hospital. Nurses are well-placed to monitor patients' responses to drugs. Spontaneous reporting of ADRs is the cornerstone of drug safety monitoring and should be the shared responsibility of all health-care staff.
- 1 February 2000
- Vol. 15 (5) , 300-4
Specialist nurse reporting of adverse drug reactions.
Up to 36% of inpatients experience an adverse drug reaction (ADR) while in hospital. Nurses are well-placed to monitor patients' responses to drugs. Spontaneous reporting of ADRs is the cornerstone of drug safety monitoring and should be the shared responsibility of all health-care staff.
- Open Access
- 1 May 1999
- Published by Oxford University Press (OUP) in Postgraduate Medical Journal
- Vol. 75 (883) , 313-315
Haemolytic anaemia associated with indinavir
Treatment for HIV infection is advancing rapidly. Many new drugs are becoming available and the life expectancy of diagnosed HIV patients has improved dramatically since the introduction of combination antiretroviral therapy. Protease inhibitors have been introduced recently; saquinavir, ritonavir, indinavir, and nelfinavir are currently available in the UK, and there are several new compounds entering the late phases of drug development. Their efficacy has been established,1 2 although less is known about their toxicity, particularly when used long-term. We report a case of severe haemolysis occurring after the initiation of indinavir therapy. Figure Changes in haemoglobin level in relation to drug therapy A 20-year-old man who was first diagnosed as being HIV positive in 1989 was referred to the Genitourinary Medicine Clinic in February 1994 with fatigue and oral candidiasis. He was treated with fluconazole. His CD4 count at the time was 310 cells/mm3. Over the next two years, the CD4 count showed a progressive decrease to below 200 cells/mm3. He refused antiretroviral therapy and prophylaxis for opportunistic infections. In June 1996, the patient was admitted with Pneumocystis carinii pneumonia (PCP) and labial herpes simplex which were treated with prednisolone, famciclovir and high-dose intravenous co-trimoxazole. He responded to the treatment and was discharged in July on PCP prophylaxis (co-trimoxazole 960 mg three times weekly). Antiretroviral therapy was again refused by the patient. The CD4+ count at the time of discharge was 77 cells/mm3, and the haemoglobin level ranged from 8.7 to 10.8 g/dl over the next 3 months. In November 1996, the patient was again admitted to hospital unwell, lethargic and anorexic. He was on oral co-trimoxazole, fluconazole, valaciclovir, and stanozolol. The haemoglobin was 10.7 g/dl (see figure) and CD4+ count was <10 cells/mm3. At this time, the patient agreed …
- 1 May 1999
- Published by Oxford University Press (OUP) in Postgraduate Medical Journal
- Vol. 75 (883) , 313-315
Open AccessHaemolytic anaemia associated with indinavir
Treatment for HIV infection is advancing rapidly. Many new drugs are becoming available and the life expectancy of diagnosed HIV patients has improved dramatically since the introduction of combination antiretroviral therapy. Protease inhibitors have been introduced recently; saquinavir, ritonavir, indinavir, and nelfinavir are currently available in the UK, and there are several new compounds entering the late phases of drug development. Their efficacy has been established,1 2 although less is known about their toxicity, particularly when used long-term. We report a case of severe haemolysis occurring after the initiation of indinavir therapy. Figure Changes in haemoglobin level in relation to drug therapy A 20-year-old man who was first diagnosed as being HIV positive in 1989 was referred to the Genitourinary Medicine Clinic in February 1994 with fatigue and oral candidiasis. He was treated with fluconazole. His CD4 count at the time was 310 cells/mm3. Over the next two years, the CD4 count showed a progressive decrease to below 200 cells/mm3. He refused antiretroviral therapy and prophylaxis for opportunistic infections. In June 1996, the patient was admitted with Pneumocystis carinii pneumonia (PCP) and labial herpes simplex which were treated with prednisolone, famciclovir and high-dose intravenous co-trimoxazole. He responded to the treatment and was discharged in July on PCP prophylaxis (co-trimoxazole 960 mg three times weekly). Antiretroviral therapy was again refused by the patient. The CD4+ count at the time of discharge was 77 cells/mm3, and the haemoglobin level ranged from 8.7 to 10.8 g/dl over the next 3 months. In November 1996, the patient was again admitted to hospital unwell, lethargic and anorexic. He was on oral co-trimoxazole, fluconazole, valaciclovir, and stanozolol. The haemoglobin was 10.7 g/dl (see figure) and CD4+ count was <10 cells/mm3. At this time, the patient agreed …
- 15 September 1998
- Vol. 94 (10) , 52-4
Reporting of adverse drug reactions: practice in the UK.
As the range of available drugs becomes increasingly wide, it is ever more important for adverse drug reactions and interactions to be reported. With the extended role of the nurse moving closer towards nurse prescribing, this article seeks to demystify the adverse drug reactions reporting system in the UK, and explain the role of nurses.
- 15 September 1998
- Vol. 94 (10) , 52-4
Reporting of adverse drug reactions: practice in the UK.
As the range of available drugs becomes increasingly wide, it is ever more important for adverse drug reactions and interactions to be reported. With the extended role of the nurse moving closer towards nurse prescribing, this article seeks to demystify the adverse drug reactions reporting system in the UK, and explain the role of nurses.